What is Glatiramer acetate?

Category: Prescription Drugs

Most popular types: Copaxone Glatopa

false

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 5,525 2,937
General health 70 50
Stiffness/spasticity 46 18
Fatigue 27 18
Pain 10 2

Show all 46 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 286
Moderate 491
Mild 1,358
None 842

Commonly reported side effects and conditions associated with Glatiramer acetate

Side effect Patients
Injection site reaction 395
Injection site pain 329
Injection site itching 280
Lumps and bumps 265
Redness 221
Bruising 154

Show all 388 reported side effects

Dosages

Based on patients currently taking Glatiramer acetate

Dosage Patients
20 mg daily 223
40 mg m,w,f 78
40 mg 3 times a week 67
40 mg every other day 18
daily 18
20 mg every other day 14
40 mg three times daily 5
20 mg 3 times a week 4
120 mg weekly 4
120 mg m,w,f 4

See all 33 dosages

Why patients stopped taking Glatiramer acetate

Multiple reasons could be selected

Reason Patients
Did not seem to work 971
Side effects too severe 768
Doctor's advice 737
Other 529
Expense 157
Personal research 135
Change in health plan coverage 83
Course of treatment ended 42
See all 2395 patients who've stopped taking Glatiramer acetate

Duration

Currently taking Glatiramer acetate

Duration Patients
1 - 6 months 8
6 months - 1 year 19
1 - 2 years 34
2 - 5 years 91
5 - 10 years 172
10 years or more 146

Stopped taking Glatiramer acetate

Duration Patients
Less than 1 month 193
1 - 6 months 409
6 months - 1 year 413
1 - 2 years 421
2 - 5 years 585
5 - 10 years 300
10 years or more 89
Adherence
Adherence Evaluations
Always 2179
Usually 575
Sometimes 100
Never taken as prescribed 123
Burden
Burden Evaluations
Very hard to take 260
Somewhat hard to take 663
A little hard to take 998
Not at all hard to take 1056
Cost per month
Cost per month Evaluations
$200+ 245
$100-199 102
$50-99 200
$25-49 488
< $25 1136
Not specified 806

What people switch to and from

Patients started taking Glatiramer acetate after stopping:

Treatment Patients
Interferon beta-1a IM Injection (Avonex) 65
Interferon beta-1a SubQ injection (Rebif) 50
Dimethyl fumarate (Tecfidera) 38
Interferon beta-1b SubQ Injection (Betaseron) 26
Natalizumab (Tysabri) 15

Show all 13 treatments patients report switching from

Patients stopped taking Glatiramer acetate and switched to:

Treatment Patients
Dimethyl fumarate (Tecfidera) 95
Natalizumab (Tysabri) 63
Teriflunomide (Aubagio) 45
Fingolimod (Gilenya) 39
Interferon beta-1a SubQ injection (Rebif) 33

Show all 25 treatments patients report switching to

Last updated:

251 patient evaluations for Glatiramer acetate

Feb 4, 2018 (Started Sep 25, 2010)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    Moderate (injection site reaction)
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 40 mg 3 times a week
Side effects: injection site reaction

Nov 14, 2016 (Started Sep 25, 2010)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    Moderate (injection site reaction)
  • Adherence
    Usually
  • Burden
    Very hard to take
Dosage: 40 mg 3 times a week
Advice & Tips: Use Shared Solutions injection reminders to help. Use a calendar to remember.
Side effects: injection site reaction

Dec 15, 2013 (Started Sep 25, 2010)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site reaction)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 20 mg Daily
Side effects: injection site reaction

Feb 26, 2011 (Started Sep 25, 2010)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Mild (injection site reaction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 20 mg Daily
Side effects: injection site reaction

  • 0 helpful marks

Dec 15, 2017 (Started Jun 09, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site lumps and bumps)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 40 mg 3 times a week
Advice & Tips: I feel like I have more energy since starting the Copaxone injections. Since going on Medicare with a Part D supplement, my out- of-pocket has gone from $0 to an average of $500/month.
Cost: $200+ monthly

Dec 12, 2016 (Started Jun 09, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site lumps and bumps)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 40 mg 3 times a week
Advice & Tips: I'm not sure yet how effective Copaxone is in reducing exacerbations, I've only taken it for 6 months.  But an unexpected positive is that I have noticed my energy level has improved - even early on in the summer (when I usually slow down a lot due to the heat), I felt an increased energy.  
Cost: < $25 monthly

  • 0 helpful marks

Sep 16, 2017 (Started Sep 15, 2015)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site bruising)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 40 mg M,W,F
Cost: < $25 monthly

Aug 25, 2013 (Started Sep 15, 2015)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Mild (injection site bruising)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Advice & Tips: There are less injection site reactions when one very carefully rotates injection sites. I track locations every night in a journal provided by Shared Solutions. I do my injections every night just before going to bed.
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 251 patient evaluations for Glatiramer acetate